OFIX Quote, Financials, Valuation and Earnings

Perspective Therapeutics has a net margin of -27.42% compared to Orthofix Medical's net margin of --. Orthofix Medical's return on equity of -27.48% beat Perspective Therapeutics's return on equity of --.

Orthofix Medical has a consensus price target of $24.40, signalling upside risk potential of 119.82%. On the other hand Perspective Therapeutics has an analysts' consensus of $13.8214 which suggests that it could grow by 478.3%. Given that Perspective Therapeutics has higher upside potential than Orthofix Medical, analysts believe Perspective Therapeutics is more attractive than Orthofix Medical.

Orthofix Medical has a beta of 0.872, which suggesting that the stock is 12.792% less volatile than S&P 500. In comparison Perspective Therapeutics has a beta of 1.112, suggesting its more volatile than the S&P 500 by 11.175%.

Orthofix Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Orthofix Medical pays -- of its earnings as a dividend. Perspective Therapeutics pays out -- of its earnings as a dividend.

Orthofix Medical quarterly revenues are $193.6M, which are larger than Perspective Therapeutics quarterly revenues of --. Orthofix Medical's net income of -$53.1M is lower than Perspective Therapeutics's net income of -$18.2M. Notably, Orthofix Medical's price-to-earnings ratio is -- while Perspective Therapeutics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Orthofix Medical is 0.53x versus 16.84x for Perspective Therapeutics. Usually stocks with elevated PS ratios are considered overvalued.

Integra Lifesciences Holdings has a net margin of -27.42% compared to Orthofix Medical's net margin of -6.61%. Orthofix Medical's return on equity of -27.48% beat Integra Lifesciences Holdings's return on equity of -1.88%.

Orthofix Medical has a consensus price target of $24.40, signalling upside risk potential of 119.82%. On the other hand Integra Lifesciences Holdings has an analysts' consensus of $16.13 which suggests that it could grow by 31.1%. Given that Orthofix Medical has higher upside potential than Integra Lifesciences Holdings, analysts believe Orthofix Medical is more attractive than Integra Lifesciences Holdings.

Orthofix Medical has a beta of 0.872, which suggesting that the stock is 12.792% less volatile than S&P 500. In comparison Integra Lifesciences Holdings has a beta of 1.268, suggesting its more volatile than the S&P 500 by 26.765%.

Orthofix Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Integra Lifesciences Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Orthofix Medical pays -- of its earnings as a dividend. Integra Lifesciences Holdings pays out -- of its earnings as a dividend.

Orthofix Medical quarterly revenues are $193.6M, which are smaller than Integra Lifesciences Holdings quarterly revenues of $382.7M. Orthofix Medical's net income of -$53.1M is lower than Integra Lifesciences Holdings's net income of -$25.3M. Notably, Orthofix Medical's price-to-earnings ratio is -- while Integra Lifesciences Holdings's PE ratio is 70.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Orthofix Medical is 0.53x versus 0.58x for Integra Lifesciences Holdings. Usually stocks with elevated PS ratios are considered overvalued.

Tactile Systems Technology has a net margin of -27.42% compared to Orthofix Medical's net margin of -4.85%. Orthofix Medical's return on equity of -27.48% beat Tactile Systems Technology's return on equity of 7.91%.

Orthofix Medical has a consensus price target of $24.40, signalling upside risk potential of 119.82%. On the other hand Tactile Systems Technology has an analysts' consensus of $13.00 which suggests that it could grow by 38%. Given that Orthofix Medical has higher upside potential than Tactile Systems Technology, analysts believe Orthofix Medical is more attractive than Tactile Systems Technology.

Orthofix Medical has a beta of 0.872, which suggesting that the stock is 12.792% less volatile than S&P 500. In comparison Tactile Systems Technology has a beta of 1.053, suggesting its more volatile than the S&P 500 by 5.279%.

Orthofix Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Tactile Systems Technology offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Orthofix Medical pays -- of its earnings as a dividend. Tactile Systems Technology pays out -- of its earnings as a dividend.

Orthofix Medical quarterly revenues are $193.6M, which are larger than Tactile Systems Technology quarterly revenues of $61.3M. Orthofix Medical's net income of -$53.1M is lower than Tactile Systems Technology's net income of -$3M. Notably, Orthofix Medical's price-to-earnings ratio is -- while Tactile Systems Technology's PE ratio is 14.27x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Orthofix Medical is 0.53x versus 0.77x for Tactile Systems Technology. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings has a net margin of -27.42% compared to Orthofix Medical's net margin of 0.18%. Orthofix Medical's return on equity of -27.48% beat Xtant Medical Holdings's return on equity of -26.62%.

Orthofix Medical has a consensus price target of $24.40, signalling upside risk potential of 119.82%. On the other hand Xtant Medical Holdings has an analysts' consensus of $1.75 which suggests that it could grow by 137.51%. Given that Xtant Medical Holdings has higher upside potential than Orthofix Medical, analysts believe Xtant Medical Holdings is more attractive than Orthofix Medical.

Orthofix Medical has a beta of 0.872, which suggesting that the stock is 12.792% less volatile than S&P 500. In comparison Xtant Medical Holdings has a beta of -0.124, suggesting its less volatile than the S&P 500 by 112.425%.

Orthofix Medical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Orthofix Medical pays -- of its earnings as a dividend. Xtant Medical Holdings pays out -- of its earnings as a dividend.

Orthofix Medical quarterly revenues are $193.6M, which are larger than Xtant Medical Holdings quarterly revenues of $32.9M. Orthofix Medical's net income of -$53.1M is lower than Xtant Medical Holdings's net income of $58K. Notably, Orthofix Medical's price-to-earnings ratio is -- while Xtant Medical Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Orthofix Medical is 0.53x versus 0.83x for Xtant Medical Holdings. Usually stocks with elevated PS ratios are considered overvalued.